Highlights
NASDAQ: CLSN       Celsion Corp
Last Price Today's Change   Day's Range   Trading Volume
2.78   -0.08 (2.80%)  2.68 - 3.00  674,917

Overview

 
Avg Volume (4 weeks):3,330,005
4 Weeks Range:1.21 - 3.65
4 Weeks Price Volatility (%):
64.34%
52 Weeks Range:0.687 - 3.65
52 Weeks Price Volatility (%):
70.64%
Average Price Target: 6.00
Price Target Upside/Downside: +3.22

Headlines



No recent Headlines for this stock.


Business Background

Celsion Corp is active in the biotechnology market. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in Phase III clinical trial for the treatment of primary liver cancer and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3156  2699  216  2889 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 TOPS 0.225+0.073 
 AAL 18.59+1.87 
 SHIP 0.169+0.032 
 HTZ 2.57+1.07 
 LK 5.51+1.46 
 OAS 1.26+0.703 
 F 7.34+0.77 
 XSPA 2.37+0.47 
 GE 7.88+0.14 
 UAL 42.405+3.305 
Partners & Brokers